Targeting BRCA1 And DNA Repair In Alzheimer’s To Prevent Or Reverse Symptoms
This article was originally published in Start Up
New research has shown that levels of the DNA repair protein BRCA1 are reduced in key parts of neurons after amyloid formation. The findings are consistent with the amyloid hypothesis and could prove to be an effective way to help prevent or reverse the symptoms of Alzheimer’s disease and other neurodegenerative diseases.
You may also be interested in...
SIRT1, the molecule activated by the controversial anti-aging supplement resveratrol, has been among the most disappointing of drug targets but now, research has linked it, along with the enzyme HDAC1, to the ability to stabilize the genome following DNA damage. The work is encouraging for the development of activators of SIRT1 and HDAC1 as neuroprotectants and DNA repair agents.
Researchers have shown that a new class of small molecule can inhibit assembly of the protein alpha-synuclein into toxic clumps, a hallmark of Parkinson’s disease. Their work supports other ongoing investigations suggesting that the compound may be useful as a neuroprotective agent for treating a range of diseases characterized by the clumping of amyloid proteins, including Alzheimer’s disease, various types of amyloidosis, and prion disease.
A series of basic research insights around the cell death process called ferroptosis could form the underpinnings of a new class of treatments aimed at drug resistant tumors.